Skip to main content
Premium Trial:

Request an Annual Quote

Lark to Provide Contract DNA Sequencing Services For ZymoGenetics

Premium

SEATTLE--Houston-based Lark Technologies has signed an agreement to provide ZymoGenetics here with contract DNA sequencing services. A subsidiary of Danish pharmaceutical company Novo Nordisk, ZymoGenetics is dedicated to the discovery of therapeutic proteins using bioinformatics.

"This is one of our largest contract agreements and we believe it illustrates the company's capacity to support significant genomic-based research programs," commented Vincent Kazmer, Lark's president and CEO. Lark was founded in 1989 by BCM Technologies, the wholly owned technology transfer subsidiary of the Baylor College of Medicine.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.